Neurocrine Biosciences Announces U.S. FDA Approval of INGREZZA® SPRINKLE (valbenazine) Capsules
SAN DIEGO, April 30, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. today announced the U.S. Food and Drug Administration has approved INGREZZA® SPRINKLE capsules, a new oral granules...